샘플 요청 목록

 카트 문의
시장보고서
상품코드
1768802

세계의 바이오 오염 제거 시장

Bio Decontamination
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 177 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 바이오 오염 제거 시장은 2030년까지 2억 6,880만 달러에 달할 전망

2024년에 2억 600만 달러로 추정되는 세계의 바이오 오염 제거 시장은 2024-2030년에 CAGR 4.5%로 성장하며, 2030년에는 2억 6,880만 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석한 부문의 하나인 장비는 CAGR 4.2%를 기록하며, 분석 기간 종료시에는 1억 2,210만 달러에 달할 것으로 예측됩니다. 서비스 분야의 성장률은 분석 기간에 CAGR 5.1%로 추정됩니다.

미국 시장은 5,620만 달러로 추정, 중국은 CAGR 4.3%로 성장 예측

미국의 바이오 오염 제거 시장은 2024년에는 5,620만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 4,230만 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2024-2030년의 CAGR은 4.3%입니다. 기타 주목할 만한 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 4.2%와 3.5%로 예측됩니다. 유럽에서는 독일이 CAGR 3.7%로 성장할 것으로 예측됩니다.

세계의 바이오 오염 제거 시장 - 주요 동향과 촉진요인 정리

오늘날 세계에서 생물학적 오염 제거가 필수적인 이유는 무엇인가?

오늘날 생물학적 오염 위험에 대한 인식이 크게 높아짐에 따라 생물학적 오염 제거는 의료, 제약, 식품 가공, 공공장소 등 다양한 산업에서 중요한 업무가 되고 있습니다. 생물학적 오염 제거는 박테리아, 바이러스, 곰팡이, 포자 등 유해한 병원균을 표면, 공기, 장비에서 표적화하여 제거하거나 비활성화하여 감염 위험을 줄이고 오염을 방지하며 제품과 사람의 안전을 보장합니다. 예를 들어 의료 환경에서는 엄격한 생물학적 오염 제거가 매년 수백만 명의 환자에게 영향을 미치고 심각한 건강 위험을 초래하는 병원내 감염(HAI)의 확산을 방지하는 데 필수적입니다. 마찬가지로 제약회사와 연구소의 오염은 미량이라도 제품 품질, 연구 성과, 규제 준수를 위협할 수 있으며, 엄격한 오염 제거 프로토콜의 중요성을 강조하고 있으며, COVID-19 팬데믹은 전 세계 조직이 직원과 고객의 안전을 보장하기 위해 접촉이 빈번한 장소를 소독하는 확실한 방법을 찾고 있습니다. 접촉이 잦은 장소를 확실하게 소독할 수 있는 방법을 찾고 있으며, 생물학적 오염 제거의 필요성을 더욱 부각시켰습니다. 감염병 예방 및 위생 표준에 대한 인식이 높아짐에 따라 생물학적 제균은 많은 산업에서 안전하고 위생적이며 규정을 준수하는 환경을 유지하는 데 필수적인 요소로 자리 잡았으며, 궁극적으로 서로 밀접하게 연결된 공간에서 공중 보건 및 안전의 초석 역할을 하고 있습니다.

어떤 첨단 기술이 바이오 오염 제거를 형성하고 있는가?

최근 기술의 발전은 생물학적 오염 제거에 혁명을 가져왔으며, 공정을 더 빠르고, 더 효과적이며, 환경 친화적으로 만드는 다양한 혁신적인 방법을 제공합니다. 가장 획기적인 기술 혁신 중 하나는 기화 과산화수소(VHP) 오염 제거의 개발입니다. 이는 과산화수소 증기를 밀폐된 환경에 분산시켜 광범위한 병원균을 제거합니다. 이 방법은 접근하기 어려운 곳까지 침투하므로 매우 효과적이며, 유해한 잔류물을 남기지 않고 복잡한 표면이나 섬세한 장비를 완전히 살균할 수 있습니다. 자외선 C(UV-C) 광기술도 널리 채택되고 있으며, 특히 병원, 실험실, 사람들이 많이 지나다니는 공공장소 등에 적합한 표면 및 공기 오염 제거를 위한 화학물질 없는 신속한 접근 방식을 제공합니다. 시스템에서 대중교통에 이르기까지 다양한 환경에서 도입되고 있습니다. 로봇 공학 및 자동화를 통해 이러한 기술은 더욱 강화되어 정확하고 일관된 적용을 가능하게 하고, 인력에 대한 의존도를 줄여 실수 가능성을 최소화하고 오염된 공간을 종합적으로 커버할 수 있게 되었습니다. 오존 오염 제거 및 이온화 과산화수소와 같은 추가 기술은 넓은 개방 공간과 공기 처리 시스템을 효과적으로 오염 제거할 수 있는 능력으로 인기를 얻고 있습니다. 이러한 기술의 발전으로 생물학적 오염 제거는 더 빠르고, 더 안전하고, 더 적응력이 높은 프로세스로 변모하여 다양한 부서가 엄격한 위생 기준을 유지하고 병원균 감염 위험을 줄일 수 있게 되었습니다.

기업이 바이오 오염 제거를 도입할 때 직면하는 과제는?

바이오 오염 제거의 도입은 분명한 장점에도 불구하고 특히 업무 중단, 규제 준수 및 비용 관리와 관련하여 큰 도전이 있습니다. VHP와 같은 많은 오염 제거 방법은 최적의 증기 농도와 효과를 보장하기 위해 공정 중에 시설을 일시적으로 폐쇄하고 기밀 상태를 유지해야 합니다. 이러한 다운타임은 병원이나 제조 공장과 같이 연속 운전이 필요한 환경에서는 특히 문제가 될 수 있습니다. 또한 엄격한 안전 및 환경 규제를 준수하는 것이 매우 중요합니다. 일부 제염 화학물질은 올바르게 적용 및 폐기하지 않으면 작업자에게 건강상의 위험을 초래하고 환경에 악영향을 미칠 수 있기 때문입니다. 헬스케어, 제약, 식품 가공 등의 산업은 규제가 엄격하고 FDA, EPA, OSHA 등의 기관이 오염 제거 프로토콜과 작업자 안전을 감독하고 있으므로 규제 준수는 이동에 있으며, 양보할 수 없는 부분입니다. 또한 전문 장비, 직원 교육, 인프라 조정 등에 대한 초기 투자비용이 많이 드는 첨단 오염 제거 기술 및 절차에 대한 비용은 소규모 조직에 큰 장벽이 될 수 있습니다. 또한 특정 환경에 적합한 제염 방법을 선택하기 위해서는 대상 병원체, 시설의 레이아웃, 처리할 표면의 특성 등의 요인을 신중하게 고려해야 하므로 더욱 복잡한 요소가 추가됩니다. 이러한 과제는 기업이 바이오 오염 제거 프로세스를 도입할 때 전략적 계획과 전문가 지도에 투자하여 업무, 안전 및 규제 요건을 효과적으로 충족시켜야 한다는 것을 보여줍니다.

바이오 오염 제거 시장의 주요 성장 촉진요인은 무엇인가?

바이오 제염 시장은 감염 예방에 대한 인식 증가, 규제 요건의 변화, 오염 제거를 보다 효율적이고 친숙하게 만드는 급속한 기술 발전에 힘입어 강력한 성장세를 보이고 있습니다. 특히 의료 환경에서 감염 관리에 대한 중요성이 강조되면서 HAI 및 기타 감염성 질환의 확산을 최소화하도록 설계된 종합적인 오염 제거 솔루션에 대한 수요가 크게 증가하고 있습니다. 특히 제약, 생명공학, 식품 가공 등 민감한 제품 및 데이터를 다루는 산업에서는 컴플라이언스를 준수하고 제품의 무결성을 유지하기 위해 입증된 오염 제거 방법을 채택해야 합니다. 또한 VHP, UV-C 광선, 로봇 시스템 등의 기술 발전으로 인해 바이오 오염 제거가 더욱 빠르고 안전하게 이루어지고 있습니다. 이러한 기술 혁신은 다양한 환경과 운영상의 제약에 적응할 수 있는 효과적인 솔루션을 제공하기 때문입니다. COVID-19를 비롯한 전염병의 유행은 공공장소에서의 생물학적 오염 제거의 중요성을 강조하고, 교통, 접객업, 소매업, 정부 시설 등 다양한 분야에서 수요 증가로 이어지고 있습니다. 소비자의 위생과 안전에 대한 인식이 높아짐에 따라 바이오 오염 제거를 우선시하는 기업을 지지하는 경향이 강해지면서 시장 확대가 더욱 가속화되고 있습니다. 이러한 촉진요인들이 결합되어 바이오 오염 제거 시장은 발전하고 있으며, 바이오 오염 제거는 다양한 산업 분야에서 위생, 안전 및 규제 준수를 유지하기 위한 세계 노력에서 중요한 역할을 하고 있습니다.

부문

제품&서비스(장비, 서비스, 소모품); 최종사용자(제약 & 의료기기 기업, 생명과학 & 바이오테크놀러지 연구기관, 병원 & 헬스케어 시설)

조사 대상 기업의 예

  • Amira S.r.l
  • ClorDiSys Solutions, Inc.
  • Ecolab
  • Fedegari Autoclavi SpA
  • Howorth Air Technology Ltd.
  • JCE Biotechnology
  • Noxilizer, Inc.
  • STERIS PLC
  • TOMI Environmental Solutions Inc.
  • Wenzhou Weike Biological Laboratory Equipment Co. Ltd.

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI 툴에 의해 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사의 국가, 제조거점, 수출입(완제품 및 OEM)을 기반으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수입원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 기타 유럽
  • 아시아태평양
  • 기타 지역

제4장 경쟁

KSA 25.07.17

Global Bio Decontamination Market to Reach US$268.8 Million by 2030

The global market for Bio Decontamination estimated at US$206.0 Million in the year 2024, is expected to reach US$268.8 Million by 2030, growing at a CAGR of 4.5% over the analysis period 2024-2030. Equipment, one of the segments analyzed in the report, is expected to record a 4.2% CAGR and reach US$122.1 Million by the end of the analysis period. Growth in the Services segment is estimated at 5.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$56.2 Million While China is Forecast to Grow at 4.3% CAGR

The Bio Decontamination market in the U.S. is estimated at US$56.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$42.3 Million by the year 2030 trailing a CAGR of 4.3% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.2% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.7% CAGR.

Global Bio Decontamination Market - Key Trends and Drivers Summarized

Why Is Bio Decontamination Essential in Today’s World?

In today’s world, bio decontamination has become a critical practice across a wide array of industries, including healthcare, pharmaceuticals, food processing, and public spaces, as the awareness of biological contamination risks has risen significantly. Bio decontamination involves the targeted removal or inactivation of harmful pathogens, such as bacteria, viruses, fungi, and spores, from surfaces, air, and equipment to reduce infection risk, prevent contamination, and ensure the safety of both products and people. In healthcare environments, for instance, rigorous bio decontamination is essential to prevent the spread of hospital-acquired infections (HAIs), which impact millions of patients annually and pose serious health risks. Similarly, in pharmaceutical manufacturing and research laboratories, contamination, even at minute levels, can compromise product quality, research outcomes, and regulatory compliance, underlining the importance of stringent decontamination protocols. The COVID-19 pandemic further highlighted the necessity of bio decontamination, as organizations worldwide sought reliable ways to sanitize high-contact areas to ensure the safety of both employees and customers. In light of the growing recognition of infection control and hygiene standards, bio decontamination has become indispensable in maintaining safe, hygienic, and compliant environments across numerous industries, ultimately serving as a cornerstone for public health and safety in increasingly interconnected spaces.

What Advanced Technologies Are Shaping Bio Decontamination?

Recent advancements in technology have revolutionized bio decontamination, offering a range of innovative methods that make the process faster, more effective, and environmentally friendly. One of the most transformative innovations has been the development of vaporized hydrogen peroxide (VHP) decontamination, which involves dispersing hydrogen peroxide vapor into a sealed environment to eliminate a broad spectrum of pathogens. This method is highly effective, as it can penetrate hard-to-reach areas, ensuring complete sterilization of complex surfaces and sensitive equipment without leaving harmful residues. Ultraviolet-C (UV-C) light technology has also become widely adopted, providing a quick, chemical-free approach to surface and air decontamination that is particularly suited for hospitals, laboratories, and high-traffic public areas. As UV-C systems become more portable and cost-effective, they are being deployed in diverse settings, from HVAC systems to public transport. Robotics and automation have further enhanced these technologies, allowing for precise, consistent application and reducing reliance on human labor, which minimizes the potential for error and ensures comprehensive coverage of contaminated spaces. Additional technologies, such as ozone decontamination and ionized hydrogen peroxide, are gaining traction for their ability to sanitize large, open areas and air handling systems effectively. Together, these technological advances are transforming bio decontamination into a faster, safer, and more adaptable process, enabling various sectors to maintain rigorous hygiene standards and reduce pathogen transmission risks.

What Challenges Do Organizations Face in Implementing Bio Decontamination?

Despite the clear benefits, implementing bio decontamination poses significant challenges, particularly related to operational disruption, regulatory compliance, and cost management. Many decontamination methods, such as VHP, require facilities to be temporarily closed off and airtight during the process to ensure optimal vapor concentration and effectiveness, which can disrupt daily operations and lead to productivity losses. This downtime can be particularly challenging in settings that require continuous operation, such as hospitals or manufacturing plants. Moreover, compliance with stringent safety and environmental regulations is crucial, as certain decontamination chemicals, if not applied and disposed of correctly, can pose health risks to personnel and have adverse environmental impacts. Industries like healthcare, pharmaceuticals, and food processing are highly regulated, with agencies like the FDA, EPA, and OSHA overseeing decontamination protocols and worker safety, making adherence to regulations a non-negotiable aspect of implementation. Additionally, the cost of advanced decontamination technologies and procedures can be a significant barrier for smaller organizations, as initial investments in specialized equipment, staff training, and infrastructure adjustments can be substantial. Choosing the appropriate decontamination method for a given environment adds another layer of complexity, requiring careful consideration of factors such as the pathogens being targeted, facility layout, and the nature of surfaces being treated. These challenges underscore the need for organizations to invest in strategic planning and expert guidance when implementing bio decontamination processes to ensure they meet operational, safety, and regulatory requirements effectively.

What Are the Key Growth Drivers in the Bio Decontamination Market?

The bio decontamination market is experiencing strong growth, fueled by rising awareness of infection prevention, evolving regulatory requirements, and rapid technological advancements that make decontamination more efficient and accessible. The emphasis on infection control, particularly in healthcare settings, has created substantial demand for comprehensive decontamination solutions designed to minimize the spread of HAIs and other infectious diseases. Regulatory agencies worldwide are enforcing stricter hygiene standards, especially for industries handling sensitive products or data, such as pharmaceuticals, biotechnology, and food processing, which are required to adopt proven decontamination methods to ensure compliance and maintain product integrity. Additionally, advancements in technologies such as VHP, UV-C light, and robotic systems are making bio decontamination faster and safer, as these innovations provide effective solutions that can adapt to various environments and operational constraints. The increased prevalence of infectious disease outbreaks, including the COVID-19 pandemic, has also underscored the importance of bio decontamination in public spaces, leading to higher demand from sectors such as transportation, hospitality, retail, and government facilities. As consumers become more aware of hygiene and safety, they are more inclined to support businesses that prioritize bio decontamination, further driving market expansion. Collectively, these drivers are propelling the bio decontamination market forward, solidifying its role as a critical component in global efforts to maintain health, safety, and regulatory compliance across a wide range of industries.

SCOPE OF STUDY:

The report analyzes the Bio Decontamination market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product & Service (Equipment, Services, Consumables); End-Use (Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations, Hospitals & Healthcare Facilities)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Amira S.r.l
  • ClorDiSys Solutions, Inc.
  • Ecolab
  • Fedegari Autoclavi SpA
  • Howorth Air Technology Ltd.
  • JCE Biotechnology
  • Noxilizer, Inc.
  • STERIS PLC
  • TOMI Environmental Solutions Inc.
  • Wenzhou Weike Biological Laboratory Equipment Co. Ltd.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Global Economic Update
    • Bio Decontamination - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Awareness of Infection Control Drives Growth in Bio Decontamination Market
    • Increasing Use of Bio Decontamination in Healthcare Expands Demand for Effective Solutions
    • Here's How Advances in Decontamination Technologies Enhance Efficacy Against Pathogens
    • Growing Focus on Patient Safety Supports Adoption of Bio Decontamination in Hospitals
    • Rising Demand for Chemical-Free Decontamination Fuels Use of UV and Vapor-Based Solutions
    • Here's How Automation in Decontamination Systems Reduces Labor Costs and Human Error
    • Focus on Minimizing Cross-Contamination Supports Demand for Routine Decontamination Protocols
    • Advancements in Portable Decontamination Devices Expand Applications Beyond Healthcare
    • Growing Demand for Decontamination Solutions in Pharmaceutical and Biotech Labs
    • Here's How Bio Decontamination Enhances Safety in Food Processing and Manufacturing
    • Rising Adoption of Remote Monitoring and Digital Controls Improves Decontamination Accuracy
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Bio Decontamination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Bio Decontamination by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Bio Decontamination by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Services by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Services by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Consumables by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Consumables by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Pharma & Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Pharma & Medical Device Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Pharma & Medical Device Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Life Sciences & Biotech Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Life Sciences & Biotech Research Organizations by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Life Sciences & Biotech Research Organizations by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals & Healthcare Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hospitals & Healthcare Facilities by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Hospitals & Healthcare Facilities by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 22: World Bio Decontamination Market Analysis of Annual Sales in US$ for Years 2015 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Bio Decontamination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • JAPAN
    • Bio Decontamination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • CHINA
    • Bio Decontamination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • EUROPE
    • Bio Decontamination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Bio Decontamination by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Bio Decontamination by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Bio Decontamination by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • FRANCE
    • Bio Decontamination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • GERMANY
    • Bio Decontamination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Bio Decontamination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: Rest of Europe 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: Rest of Europe 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Bio Decontamination Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: Asia-Pacific 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Asia-Pacific 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Bio Decontamination by Product & Service - Equipment, Services and Consumables - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Bio Decontamination by Product & Service - Equipment, Services and Consumables Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of World 15-Year Perspective for Bio Decontamination by Product & Service - Percentage Breakdown of Value Sales for Equipment, Services and Consumables for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Bio Decontamination by End-Use - Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of World 15-Year Perspective for Bio Decontamination by End-Use - Percentage Breakdown of Value Sales for Pharma & Medical Device Companies, Life Sciences & Biotech Research Organizations and Hospitals & Healthcare Facilities for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제